)
Nikita Vashisht is a business journalist tracking equity markets for Business Standard. She writes stories based on fundamental analysis of stocks of banking, aviation, FMCG, infrastructure, real estate, and new-age companies. Occasionally, she also writes on investment strategies for mutual fund investors. Nikita holds a degree in journalism, and business management, and is a certified fundamental and technical analyst for stocks and commodities.
Nikita Vashisht is a business journalist tracking equity markets for Business Standard. She writes stories based on fundamental analysis of stocks of banking, aviation, FMCG, infrastructure, real estate, and new-age companies. Occasionally, she also writes on investment strategies for mutual fund investors. Nikita holds a degree in journalism, and business management, and is a certified fundamental and technical analyst for stocks and commodities.
Stocks to Watch on Friday, October 27, 2023: Tata Sons, the holding company of the Tata group, will have to infuse an additional Rs 2,055 crore in its loss-making subsidiary Tata Teleservices
Maruti Suzuki India Q2 preview: At the bottomline level, analysts expect the company's standalone net profit to rise up to 66 per cent year-on-year
Stocks to watch on Thursday, October 26: The consolidated net profit of Tech Mahindra for Q2FY24 fell 61.10 per cent YoY to Rs 505.30 crore -- the biggest drop in 16 years
Stocks to watch on Wednesday, October 25, 2023: The Bombay High Court has directed the Directorate General of GST Intelligence, Hyderabad, to not pass a final orders against Delta Corp
Over the past three months, shares of ICICI Bank have slipped 6.7 per cent on the bourses as against HDFC Bank's 10.14 per cent correction
Stocks to Watch on Monday, October 23, 2023: Paytm said its revenue increased 32 per cent YoY to Rs 2,519 crore in the second quarter, with its consolidated net loss narrowing to Rs 291 crore
Bajaj Finance stock: During the recently concluded quarter, Bajaj Finance saw 29 bps year-on-year (YoY) and 11 bps quarter-on-quarter (QoQ) decline in NIM to 10.5 per cent
HDFC Bank stock: HDFC Bank has made a good beginning after the merger, and given a huge pace of capacity building, we believe that there are levers in place to sustain this momentum in business growth
HDFC Bank Q2 results: Q2-FY24 will be the first quarter post the merger and, thus, there is likely to be a fair degree of volatility over estimates, analysts said
Stocks to Watch on Friday, October 6, 2033: SoftBank Group is likely to sell shares worth up to $105 million in PB Fintech via block deals
Stocks to Watch on Thursday, October 5, 2023: The government, on Wednesday, released the fifth Positive Indigenisation List (PIL) of 98 items which will be procured by the three armed services
Headwinds for the airlines and QSR sectors, analysts believe, could outweigh the positives in the form of a demand uptick
Stocks to Watch on Wednesday, October 4, 2023: Bajaj Finserv's insurance arm, Bajaj Allianz General Insurance has received a show cause notice alleging a tax demand of Rs 1,010.05 crore
According to analysts, the bank's management has a multipronged growth strategy, leading to a compelling investment argument
Stocks to Watch on Tuesday, October 3, 2023: JSW Infrastructure will debut on the bourses on October 3, 2023
Discount brokers have sustained the rise of the equity cult and gained market share. Now the old guard looks to strike back
The Board of Bajaj Finance is scheduled to meet next week to consider proposal for raising of funds through any or all of various methods including by way of preferential issue or QIP
Burman family, which holds a controlling stake in Dabur, announced an open offer for a 26 per cent stake in Religare Enterprises for up to Rs 2,116 crore
The rally in PSBs, analysts feel, was more a knee-jerk reaction to the development, and the actual benefits will start to accrue once the addition takes place in 2024
Stocks to Watch today, September 22, 2023: Glenmark Pharmaceuticals Board has approved the divestment of a 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma for Rs 5,651 crore